Dan Zabrowski, PhD
Dr. Zabrowksi worked for over 20 years at Roche, where he oversaw over 300 acquisition and partnership deals and held a number of key global leadership positions, including President of Ventana Medical Systems, Global Head of Regulatory Affairs, Global Head of Development Operations, Global Head of Roche Pharma Partnering and President of the Roche Sequencing Unit. Dr. Zabrowski has previously served as a member of Roche’s Enlarged Corporate Executive Committee and as a director of Chugai Pharmaceuticals. Dr. Zabrowski received his PhD in Organic Chemistry from Indiana University, Bloomington and his BA in Chemistry from Saint Louis University.
Shawn Marcell
Mr. Marcell has over 25 years of experience co-founding, chairing and leading the growth of numerous venture-backed companies in the life sciences, including ReedCoor, MetaMark Genetics (acquired by P4 Diagnostix in 2016), SensiGen (acquired by Sequenom in 2013), Lifecodes (division of Hologic, acquired by Immucor in 2009), and RedPoint Bio (public in 2005). Mr. Marcell earned a BA in Economics from George Washington University.
Hillel Bachrach, MBA
Mr. Bachrach is the Managing Partner and Executive Chairman of 20/20 HealthCare Partners LLC. Previously, Mr. Bachrach served as the Executive Chairman of Viztek (acquired by Konica Minolta in 2015), President of Odin Medical Technologies (acquired by Medtronic in 2006), President and CEO of OREX Computed Radiography (acquired by Kodak in 2005), helped found UltraSPECT, co-founded MSq (now Alma Lasers, acquired by Fosun Pharma) and co-founded and served as the Executive Vice President and Vice Chairman of ESC Medical Systems (public in 1996, now Lumenis). Mr. Bachrach holds an MBA from Northwestern University’s J.L. Kellogg Graduate School of Management and a BS in Electronic Engineering from the Technion Israeli Institute of Technology.
Derek Lee
Mr. Lee is the founder and managing director of DHL Ventures LLC, and senior advisor at Athyrium Capital Management LP. Mr. Lee has co-founded, invested in and advised companies across biotechnology, medical devices and healthcare services, and previously served as founder, CFO and CDO of Talaris Advisors, a senior analyst at Burrage Capital, a principal at SV Life Sciences and held investment banking positions in the Global Healthcare Group at UBS Warburg and in the Healthcare Investment Banking Group at Salomon Smith Barney. Mr. Lee earned a BS in Finance, Accounting and Economics from Bentley University.
Susan Volkert, JD, LLM
Ms. Volkert is currently a litigation Partner at DeCoitis, FitzPatrick & Cole, LLP, and previously served as Chief Compliance Officer, Vice President and Deputy General Counsel of Hoescht Celanese (Sanofi Aventis). Ms. Volkert served as the Deputy Chief of the Torts and Commercial Litigation Branches of the U.S. Department of Justice in Washington, D.C., and as the Deputy Chief of the Civil Division of the the U.S. Attorney’s Office for the District of New Jersey. Ms. Volkert is a graduate of UPenn and the University of Toledo Law School and holds an LLM in Health Law from Seton Hall University School of Law.